Metrics as of 10/17/2026, 09:31 AM (Berlin time), refresh in progress.
IVF Hartmann Holding AG
IVF Hartmann Holding AG is a healthcare company headquartered in Neuhausen am Rheinfall, Switzerland. Founded in 1870, the company went public on the SIX exchange on April 12, 1995. With 311 employees, the firm provides medical consumer goods both in Switzerland and internationally. The product portfolio includes…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
1D
-0.8%
1W
-1.2%
1M
+0.8%
6M
-8.8%
YTD
-13.3%
1Y
-9.8%
2Y
-10.1%
5Y
-11.4%
10Y
-38.9%
Next earnings date
No date known
Volatility around earnings
~2% stronger price swings than usual
P/E
14.57
P/B
1.89
EV/EBITDA
7.93
RETURN ON EQUITY
6.6%
NET MARGIN
12.0%
DEBT/EQUITY
0.03
DIVIDEND YIELD
3.1%
AS OF
30/06/2026
FREE FLOAT
23.2%
FLOAT SHARES
553,639
AVG. DAILY VOLUME (30D)
197
IVF Hartmann Holding AG is a company in the Healthcare sector, Medical - Specialties industry, headquartered in Switzerland.
The CEO is Martin Walther, the company employs around 311 people.
The IPO was on 12/04/1995; the stock trades on SIX under the ticker VBSN.SW.
Around past earnings, price swings were roughly 2% stronger than usual.
Yes. The last dividend was CHF 3.80 per share, ex-date 16/04/2026, paid on 20/04/2026.
The dividend yield is 3.1% (as of 30/06/2026).
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Roche Holding, BeOne Medicines and Sandoz Group.
Clicking "Analyze stock" lets five strategies assess IVF Hartmann Holding against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.